Access to Over the Counter (OTC) Drug Utilization Data
Contact and place of performance
Benjamin Golway
Silver Spring, MD 20993
USA
05/28/2020 - Amendment2 to FDA-RFP-1228764"Access to Over-the-Counter (OTC) Drug Utilization Data/Services" is posted to revise evaluation Factor 3. Pleaserefer to the attached RFP (Amendment 2). RFP revisions are highlighted in yellow in Amendment 2.
The Food and Drug Administration (FDA) Office of Acquisition and Grant Services issued solicitation FDA-RFP-1228764 to obtain access to Over-the-Counter (OTC) drug utilization data and related services. This requirement is classified under NAICS 541519, Other Computer Related Services, and PSC DA10, IT and Telecom - Business Application/Application Development Software as a Service. The project supports the agency's need for comprehensive data regarding the usage of non-prescription medications, with performance located in Silver Spring, Maryland.
The procurement is conducted as a combined synopsis and solicitation with a response deadline of June 8, 2020. Administrative updates to the requirement include five total attachments, featuring amendments to the Request for Proposals (RFP) and official responses to vendor questions. Specifically, Amendment 2 was issued on May 28, 2020, to revise the criteria for evaluation Factor 3. Benjamin Golway serves as the primary point of contact for this federal opportunity.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.